UnknownNot Applicable

A Novel Oral Natural Extract for the Treatment of Senile Purpura

United States75 participantsStarted 2008-11

Plain-language summary

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with evidence of purpura on physical exam Exclusion Criteria: * Preexisting condition that would not allow the patients to take oral calcium supplement

What they're measuring

IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA

Timeframe: 6 WEEKS

Trial details

NCT IDNCT01183910

SponsorNexgen Dermatologics, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-07

View on ClinicalTrials.gov More PURPURA trials